Search results for " Extrahepatic"

showing 10 items of 10 documents

Extrahepatic Manifestations of Chronic Viral C Hepatitis.

2020

Hepatits C virus (HCV) infection has been largely associated with extrahepatic comorbidities such as diseases related to dysregulation of the immune system, neuropsychiatric disorders, and cardiometabolic alterations. These clinical consequences, together with experimental evidence, suggest a potential (in)direct effect of HCV, contributing to the pathogenesis of these diseases. Various studies have reported a positive effect of viral eradication on occurrence and outcomes of extrahepatic diseases. These observations and the availability of safe and effective direct antiviral agents further underline the need to search for virological eradication in all infected individuals independent of t…

0301 basic medicineRiskSustained Virologic Responsemacromolecular substancesAntiviral AgentsVirusPathogenesisCohort Studies03 medical and health sciencesLiver disease0302 clinical medicineImmune systemDiabetes mellitusmedicineHepatitisbusiness.industryLymphoma Non-HodgkinMental DisordersGastroenterologyHepatitis C Chronicmedicine.diseaseCardiovascular disease Diabetes Extrahepatic complications HCV Immune-related disorders Kidney disease030104 developmental biologyCross-Sectional StudiesCryoglobulinemiaCardiovascular DiseasesImmunology030211 gastroenterology & hepatologybusinessKidney diseaseGastroenterology clinics of North America
researchProduct

Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicen…

2019

Abstract Background and Aims Primary sclerosing cholangitis [PSC] is usually associated with inflammatory bowel disease [IBD]. An increased risk of malignancies, mainly colorectal cancer [CRC] and cholangiocarcinoma [CCA], has been reported in PSC-IBD patients. Our aim was to determine the clinical characteristics and management of PSC in IBD patients, and the factors associated with malignancies. Methods PSC-IBD patients were identified from the Spanish ENEIDA registry of GETECCU. Additional data were collected using the AEG-REDCap electronic data capture tool. Results In total, 277 PSC-IBD patients were included, with an incidence rate of 61 PSC cases per 100 000 IBD patient-years, 69.7% …

AdultMalemedicine.medical_specialtyendocrine system diseasesColorectal cancerCholangitis SclerosingRisk AssessmentGastroenterologyInflammatory bowel diseasedigestive systemPrimary sclerosing cholangitisCholangiocarcinomaBile Ducts ExtrahepaticRisk FactorsInterquartile rangeinflammatory bowel diseaseInternal medicineHumansMedicineRetrospective Studiesbusiness.industryPrimary sclerosing cholangitisHazard ratiodigestive oral and skin physiologyGastroenterologyRetrospective cohort studyGeneral MedicineOdds ratioMiddle AgedInflammatory Bowel Diseasesmedicine.diseaseSurvival AnalysisUlcerative colitisdigestive system diseasesPatient Care ManagementBile Ducts IntrahepaticSpainFemalePrimary sclerosing cholangitis inflammatory bowel disease malignancyColorectal Neoplasmsbusinessmalignancy
researchProduct

Diagnosis of sclerosing cholangitis in children: blinded, comparative study of magnetic resonance versus endoscopic cholangiography.

2013

Summary Background Magnetic resonance cholangiography (MRC) has been validated as comparable to endoscopic retrograde cholangiography (ERC) for the diagnosis of sclerosing cholangitis (SC) in adult patients. In children, MRC is widely used based mainly on non-comparative studies. Patients and methods ERCs and MRCs of seven children (median age 9, range: 7–20 years) with SC and 17 controls (median age 6, range: 2 months–20 years) with other chronic liver diseases were reviewed in a blinded, random and independent way. All patients underwent both examinations within a 6-months slot. All ERCs and 17 MRCs were performed under general anesthesia. One radiologist evaluated both ERCs and MRCs and …

MaleCholangitisSclerosingCholangiographyEndoscopic RetrogradeBile Ducts ExtrahepaticROCYoung adultChildIntrahepaticCholangiopancreatography Endoscopic RetrogradeObserver Variationmedicine.diagnostic_testBile ductGastroenterologyERCMagnetic resonance cholangiographyMagnetic Resonance Imagingsclerosing cholangitiCholangiopancreatographyMRCmedicine.anatomical_structurePredictive value of testsChild PreschoolFemaleRadiologymedicine.medical_specialtyEndoscopic retrograde cholangiographyAdolescentERC; Endoscopic retrograde cholangiography; MRC; Magnetic resonance cholangiography; ROC; Receiver operating curves; SC; Sclerosing cholangitis; Adolescent; Bile Ducts Extrahepatic; Bile Ducts Intrahepatic; Case-Control Studies; Child; Child Preschool; Cholangitis Sclerosing; Female; Humans; Infant; Male; Observer Variation; Predictive Value of Tests; ROC Curve; Retrospective Studies; Sensitivity and Specificity; Young Adult; Cholangiopancreatography Endoscopic Retrograde; Magnetic Resonance Imaging; GastroenterologyCholangitis SclerosingSocio-culturaleIntrahepatic bile ductsExtrahepaticSensitivity and SpecificityYoung AdultPredictive Value of TestsmedicineHumansSCPreschoolRetrospective StudiesHepatologyReceiver operating curvesbusiness.industryInfantMagnetic resonance imagingRetrospective cohort studyGold standard (test)Bile Ducts IntrahepaticROC CurveCase-Control StudiesBile DuctsbusinessSclerosing cholangitisClinics and research in hepatology and gastroenterology
researchProduct

Permanent stenting in “unextractable” common bile duct stones in high risk patients. A prospective randomized study comparing two different stents

2007

BACKGROUND: Endoscopic sphincterotomy (ES) and stone extraction is the treatment of choice for bile duct stones. Therefore, if ES and conventional stone extraction fail, further treatment is mandatory. Insertion of a biliary endoprosthesis is an effective option. MATERIALS AND METHODS: We treated 30 high-risk patients (17 women and 13 men, mean age 82 years) affected by difficult common bile duct stones. The patients were randomly assigned preoperatively using closed envelopes (blind randomization) into two groups to receive insertion of polyethylene or hydrophilic hydromer-coated polyurethane stent, respectively. Follow-up was achieved by contacting referring physicians and patient's relat…

Malemedicine.medical_specialtyPalliative caremedicine.medical_treatmentPolyurethanesComorbidityGallstonesSphincterotomy EndoscopicPostoperative ComplicationsCoated Materials BiocompatibleLiver Function TestsCholestasisRisk FactorsCause of DeathmedicineHumansAgedAged 80 and overCholangiopancreatography Endoscopic RetrogradePermanent stenting difficult stones prospective study stentsCommon bile ductBile ductbusiness.industryPalliative CarePovidoneStentEquipment DesignCholestasis ExtrahepaticVascular surgerymedicine.diseaseSettore MED/18 - Chirurgia Generalemedicine.anatomical_structurePolyethyleneCardiothoracic surgeryEquipment FailureFemaleStentsSurgeryRadiologybusinessFollow-Up StudiesIsocyanatesAbdominal surgeryLangenbeck's Archives of Surgery
researchProduct

Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control stud…

2007

OBJECTIVES: To identify risk factors of carcinoma of the extrahepatic biliary tract in men. METHODS: Newly diagnosed and histologically confirmed patients, 35-70 years old, were interviewed between 1995 and 1997 in Denmark, Sweden, France, Germany and Italy. Population controls were frequency-matched by age and region. Adjusted odds ratios and 95%-confidence intervals were estimated by logistic regression. RESULTS: The analysis included 153 patients and 1421 controls. The participation proportion was 71% for patients and 61% for controls. Gallstone disease was corroborated as a risk factor for extrahepatic biliary tract carcinoma in men (odds ratio 2.49; 95% confidence interval 1.32-4.70), …

MaleobesityEtiologyEpidemiologyMedizinGastroenterologyBody Mass Index0302 clinical medicineBile Ducts ExtrahepaticCholelithiasisRisk FactorsMedicineAlcohol consumption2. Zero hungerBiliary tract neoplasmeducation.field_of_studySmokingGastroenterologyCase-control studyMenGallstonesMiddle Agedmedical history3. Good healthBiliary tract carcinomaBiliary Tract Neoplasms030220 oncology & carcinogenesisMedical history030211 gastroenterology & hepatologyGallbladder NeoplasmsepidemiologyGallbladder carcinomaAdultmedicine.medical_specialtyAmpulla of Vateralcohol consumptioncase-control studyetiologyPopulationCommon Bile Duct Neoplasmsmensmoking03 medical and health sciencesInternal medicinesmoking.HumansObesityRisk factoreducationLife StyleAgedbiliary tract carcinomaHepatologybusiness.industryCase-control studyOdds ratiomedicine.diseaseConfidence interval[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieCase-Control Studies[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiegallbladder carcinomabusinessBody mass index
researchProduct

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab

2020

Abstract Background & Aims Radiological progression patterns to first‐line sorafenib have been associated with post‐progression and overall survival in advanced hepatocellular carcinoma, but these associations remain unknown for therapies in second‐ and later‐line settings. This post hoc analysis of REACH and REACH‐2 examined outcomes by radiological progression patterns in the second‐line setting of patients with advanced hepatocellular carcinoma treated with ramucirumab or placebo. Methods Patients with advanced hepatocellular carcinoma, Child‐Pugh A and Eastern Cooperative Oncology Group Performance Status 0 or 1 with prior sorafenib were randomized to receive ramucirumab 8mg/kg or place…

OncologySorafenibLiver CancerMalemedicine.medical_specialtyCarcinoma HepatocellularramucirumabPopulationRadioteràpiaAntineoplastic AgentsPlaceboAntibodies Monoclonal HumanizedRamucirumabLesionCàncer de fetge03 medical and health sciencesbest supportive care0302 clinical medicineInternal medicinePost-hoc analysisMedicineHumanseducationdisease progression patternseducation.field_of_studyHepatologyRadiotherapybusiness.industryProportional hazards modelLiver NeoplasmsMiddle AgedSorafenibmedicine.diseaseTreatment Outcome030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyOriginal Articlemedicine.symptombusinesspost‐progression survivalnew extrahepatic lesionLiver cancermedicine.drug
researchProduct

Experimentally Induced Biliary Atresia by Means of Rotavirus‐Infection Is Directly Linked to Severe Damage of the Microvasculature in the Extrahepati…

2018

Abstract: Vascular damage has been reported to contribute to atresia formation in several diseases including biliary atresia. This study focused on the extrahepatic biliary plexus in experimental biliary atresia. Newborn BALB/cAnNCrl-pups were infected with rhesus rotavirus within 24 hr after birth to induce experimental biliary atresia. The extrahepatic biliary plexus was examined by confocal microscopy on whole-mount preparations, scored by three independent researchers, and further evaluated at the subcellular level with transmission electron microscopy. Imaging results revealed a progressive destruction of the extrahepatic biliary vascular plexus in the course of experimental biliary at…

Rotavirus0301 basic medicinePathologymedicine.medical_specialtyHistologyNecrosismedicine.disease_causeRotavirus InfectionsMicrocirculationPathogenesisMice03 medical and health sciences0302 clinical medicineMicroscopy Electron TransmissionBile Ducts ExtrahepaticBiliary AtresiaBiliary atresiaRotavirusmedicineAnimalsHumansEcology Evolution Behavior and SystematicsMice Inbred BALB CPlexusMicroscopy Confocalbusiness.industryBile ductmedicine.diseaseDisease Models Animal030104 developmental biologymedicine.anatomical_structureAnimals NewbornAtresiaMicrovesselsDisease ProgressionFemaleHuman medicineAnatomymedicine.symptombusiness030217 neurology & neurosurgeryBiotechnologyThe Anatomical Record
researchProduct

A small-bowel segment as a total extrahepatic bile duct replacement.

1992

• The effect of a small-bowel segment as a total extrahepatic bile duct replacement, with preservation of the bile passage through the papilla of Vater, was examined in 12 pigs followed up for 420 days. No complications during or after surgery were observed in any of the animals. The laboratory parameters were within normal range during the entire observation period. No anastomotic stenosis was evident on percutaneous transhepatic cholangiography in animals examined 2, 6, or 12 months after surgery. The intrahepatic biliary tract was not dilated. There was obvious peristalsis of the grafted small-bowel toward the papilla of Vater. Autopsies showed that the grafts had healed without any sign…

medicine.medical_specialtyAmpulla of VaterSwinemedicine.medical_treatmentBiopsyAnastomosisPercutaneous transhepatic cholangiographyGastroenterologyPostoperative ComplicationsBile Ducts ExtrahepaticInternal medicineIntestine SmallmedicineAnimalsCholestasismedicine.diagnostic_testBile ductbusiness.industrymedicine.diseaseSmall intestineSurgeryMajor duodenal papillaStenosismedicine.anatomical_structureLiverLiver biopsyCholedochostomySwine MiniatureSurgerybusinessDuct (anatomy)CholangiographyArchives of surgery (Chicago, Ill. : 1960)
researchProduct

Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-ana…

2020

Background Cholangiocarcinoma is a cancer with poor prognosis. The detection of risk factors is fundamental to identify subjects at higher risk of cholangiocarcinoma. Nonalcoholic fatty liver disease (NAFLD) represents a leading cause of chronic liver disease worldwide. Recent data suggested that NAFLD increases the risk of cholangiocarcinoma development. However, it is necessary to better explain the strength of association between NAFLD and cholangiocarcinoma. Methods A systematic research of current case-control, cohort, clinical trial and meta-analysis on the main electronic databases was made. A recent systematic review was recognized. We performed cumulative meta-analyses with sensiti…

medicine.medical_specialtyChronic liver diseasedigestive systemGastroenterologyCholangiocarcinoma03 medical and health sciences0302 clinical medicineNon-alcoholic Fatty Liver DiseaseInternal medicineNonalcoholic fatty liver diseasemedicineHumansIntrahepatic CholangiocarcinomaHepatologybusiness.industryConfoundingLiver NeoplasmsGastroenterologyOdds ratiomedicine.diseasedigestive system diseasesConfidence intervalClinical trialBile Ducts IntrahepaticBile Duct Neoplasms030220 oncology & carcinogenesisMeta-analysisliver Intrahepatic Cholangiocarcinoma extrahepatic Cholangiocarcinoma030211 gastroenterology & hepatologybusiness
researchProduct

Expression of Cytokeratin 7 and 20 in Pathological Conditions of the Bile Tract

2003

Expression of cytokeratin 7 (CK7) and cytokeratin 20 (CK20) helps to establish the origin of biliary and metastatic carcinomas. We investigated the expression of CK7 and CK20 in inflammatory, metaplastic and neoplastic conditions of the bile ducts, and evaluated possible relationships between the CK expression pattern and extrahepatic bile duct/gallbladder carcinomas (EBDCs) or intrahepatic bile duct carcinomas (IBDCs). We used immunohistochemistry for the investigation of 48 formalin-fixed, paraffin-embedded specimens grouped as: A) lithiasic or inflamed surgically resected extrahepatic bile ducts/gallbladders: all were CK7+/CK20+; B) percutaneous liver biopsies from patients with chronic …

medicine.medical_specialtyPathologyIntestinal metaplasia2734Intrahepatic bile ductsBile duct tumors; Cytokeratin 20 (CK20); Cytokeratin 7 (CK7); Intestinal metaplasia; Bile Duct Diseases; Bile Duct Neoplasms; Bile Ducts Extrahepatic; Bile Ducts Intrahepatic; Carcinoma; Cell Transformation Neoplastic; Gallbladder Diseases; Gallbladder Neoplasms; Gene Expression Profiling; Humans; Immunohistochemistry; Intermediate Filament Proteins; Keratin-20; Keratin-7; Keratins; 2734Bile Duct DiseasesGallbladder DiseasesKeratin-20Settore MED/08 - Anatomia PatologicaGastroenterologyIntermediate Filament ProteinPathology and Forensic MedicinePrimary sclerosing cholangitisCytokeratinPrimary biliary cirrhosisIntermediate Filament ProteinsBile Ducts ExtrahepaticInternal medicineBile duct tumormedicineHumansCytokeratin 7 (CK7)Bile Duct NeoplasmGallbladder NeoplasmBile ductbusiness.industryGene Expression ProfilingGallbladderKeratin 20CarcinomaGallbladder DiseaseKeratin-7Bile Duct DiseaseCell Biologymedicine.diseaseImmunohistochemistryBile Ducts IntrahepaticCell Transformation Neoplasticmedicine.anatomical_structureBile Duct NeoplasmsKeratinKeratin 7KeratinsGallbladder NeoplasmsbusinessCytokeratin 20 (CK20)HumanPathology - Research and Practice
researchProduct